Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.79B |
| 2 |
Meta Platforms (Facebook)
META
|
+$838M |
| 3 |
TotalEnergies
TTE
|
+$638M |
| 4 |
UnitedHealth
UNH
|
+$477M |
| 5 |
Coca-Cola
KO
|
+$385M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$841M |
| 2 |
TSMC
TSM
|
+$665M |
| 3 |
Philip Morris
PM
|
+$629M |
| 4 |
Citigroup
C
|
+$475M |
| 5 |
Microsoft
MSFT
|
+$475M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.25% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 10.33% |
| 4 | Consumer Discretionary | 9.42% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Traeger
COOK
$169M
| $87.3K | ﹤0.01% |
1,616
-14
| -0.9% | -$681 |
|
|
ASM
4002
Avino Silver & Gold Mines
ASM
$1.22B
| $85.3K | ﹤0.01% |
13,730
+1,805
| +15% | +$9.71K |
|
4003
Harvard Bioscience
HBIO
$30M
| $84.4K | ﹤0.01% |
12,622
| – | – |
|
4004
OPAL Fuels
OPAL
$68.3M
| $82.9K | ﹤0.01% |
35,191
-2,040
| -5% | -$4.92K |
|
4005
Karyopharm Therapeutics
KPTI
$45.8M
| $81.6K | ﹤0.01% |
11,087
+1
| +0% | +$6 |
|
4006
DLH Holdings
DLHC
$68.6M
| $80.9K | ﹤0.01% |
14,310
-7,982
| -36% | -$46.4K |
|
4007
Lantern Pharma
LTRN
$34.1M
| $80.2K | ﹤0.01% |
26,481
| – | – |
|
4008
CervoMed
CRVO
$40.6M
| $79K | ﹤0.01% |
+10,003
| New | +$80.4K |
|
4009
Key Tronic
KTCC
$42.7M
| $78.8K | ﹤0.01% |
28,237
| – | – |
|
|
TVRD
4010
Tvardi Therapeutics
TVRD
$21.9M
| $78K | ﹤0.01% |
18,146
+8,480
| +88% | +$76K |
|
|
SVCO
4011
Silvaco Group
SVCO
$257M
| $77.5K | ﹤0.01% |
19,141
+5,054
| +36% | +$25.1K |
|
|
ACTU
4012
Actuate Therapeutics
ACTU
$23.2M
| $76.9K | ﹤0.01% |
+12,565
| New | +$86.3K |
|
4013
Ultralife
ULBI
$120M
| $72.8K | ﹤0.01% |
12,730
-10,776
| -46% | -$66.5K |
|
4014
AirSculpt Technologies
AIRS
$244M
| $72.1K | ﹤0.01% |
36,389
-420
| -1% | -$2.55K |
|
4015
Mobile Infrastructure Corp
BEEP
$113M
| $71.1K | ﹤0.01% |
27,883
-854
| -3% | -$2.67K |
|
|
BTX
4016
BlackRock Technology and Private Equity Term Trust
BTX
$1.06B
| $71K | ﹤0.01% |
10,778
| – | – |
|
|
SLSN
4017
Solesence Inc
SLSN
$71.3M
| $70.3K | ﹤0.01% |
44,073
-1,184
| -3% | -$3.21K |
|
4018
Neumora Therapeutics
NMRA
$324M
| $70.1K | ﹤0.01% |
39,181
+19,345
| +98% | +$42.4K |
|
4019
Annovis Bio
ANVS
$76.1M
| $69.4K | ﹤0.01% |
20,058
+1,000
| +5% | +$3.01K |
|
|
DDL
4020
Dingdong
DDL
$516M
| $69.1K | ﹤0.01% |
27,739
+1,005
| +4% | +$2K |
|
4021
Telomir Pharmaceuticals
TELO
$73.6M
| $68.4K | ﹤0.01% |
51,454
| – | – |
|
4022
Southland Holdings
SLND
$30.2M
| $67.2K | ﹤0.01% |
20,243
+698
| +4% | +$2.75K |
|
|
NOTV
4023
DELISTED
Inotiv
NOTV
| $65.2K | ﹤0.01% |
116,037
| – | – |
|
4024
Myomo
MYO
$60.2M
| $64.3K | ﹤0.01% |
70,667
-2,188
| -3% | -$2.1K |
|
4025
BGSF Inc
BGSF
$58.7M
| $57.9K | ﹤0.01% |
12,498
+1
| +0% | +$4 |
|
Similar funds
Bank of New York Mellon's Q4 2025 Portfolio in Review
As of Q4 2025, Bank of New York Mellon held 4,340 positions worth $568B, up 1.8% from $557B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Bank of New York Mellon's Q4 2025 filing shows 170 new, 1,819 increased, 2,090 reduced and 159 closed positions. Its largest new stake was Horizon International Managed Risk ETF: 14,143,461 shares worth $363M. The largest sale was Amphenol, an estimated $841M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2025 buy was Horizon International Managed Risk ETF: 14,143,461 shares worth $363M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q4 2025, an estimated $1.79B increase.
- Bank of New York Mellon's biggest Q4 2025 reduction was Amphenol, cutting an estimated $841M.
- Bank of New York Mellon fully exited Interpublic Group of Companies in Q4 2025, selling an estimated $121M.
- Bank of New York Mellon's ten largest holdings make up 28% of its $568B portfolio in Q4 2025.
- Bank of New York Mellon opened 170 new positions and closed 159 in Q4 2025.
- Bank of New York Mellon's portfolio value rose 1.8% quarter-over-quarter to $568B.
Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.